Knowledge and use of different breast cancer screening tools among primary care physicians
A cross-sectional study
DOI:
https://doi.org/10.29193/RMU.38.3.4Keywords:
BREAST CANCER, SCREENING, MAMMOGRAPHYAbstract
Introduction: in Uruguay, breast cancer (BC) is the leading cause of cancer incidence and mortality in women.
Objective: to understand the implementation of BC screening among primary care physicians in routine clinical practice and the degree of adherence to the recommendations put forward in 2015 by the Ministry of Public Health (MPH) for the early detection of BC.
Materials and methods: this was a descriptive, cross-sectional, observational study. An anonymous survey was administered to physicians working in primary care.
Results: 169 physicians were included, 89.4% (151) consider the use of screening mammography decreases mortality from BC, 54.4% (92) indicate mammography from 40 years of age and 38.5% (65) from 50 years of age. The majority (56.8%, 96) indicate mammography every 2 years in the population of women aged 50-69 years. Of the respondents, 65.7% (111) were aware of the national guidelines and 47.9% (81) followed them, while 18.9% (32) followed recommendations from other scientific bodies.
Conclusion: this study showed that primary care physicians make correct use of the different BC screening tools. Active measures are needed to develop educational programs for healthcare personnel, which may enable them to disseminate knowledge and positively influence patients’ attitudes.
References
1) International Agency for Research on Cancer. Global Cancer Observatory. Disponible en: https://gco.iarc.fr/ [Consulta: 24 setiembre 2021].
2) Comisión Honoraria de Lucha Contra el Cáncer. Informe Anual. Periodo 2012-2016. Disponible en: https://www.comisioncancer.org.uy/Ocultas/RESUMENES-ESTADISTICOS-Periodo-2013-2017-uc264 [Consulta: 24 setiembre 2021].
3) Barrios E, Garau M. Cáncer: magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos. Anafamed 2017; 4(1):9-46.
4) Comisión Honoraria de Lucha Contra el Cáncer. Registro Nacional de Cáncer. Situación epidemiológica del Uruguay-Mayo 2022. Montevideo: CHLCC. Disponible en: https://www.comisioncancer.org.uy/Ocultas/Situacion-Epidemiologica-del-Uruguay-en-relacion-al-Cancer--Mayo-2019-uc108 [Consulta: 12 abril 2021].
5) Fletcher RH, Fletcher SW, Fletcher GS. Clinical epidemiology: The essentials. 5th ed. Philadelphia: Lippincott, 2013. 255 p.
6) Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151(10): 727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009.
7) Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2019; 69(3):184-210. doi: 10.3322/caac.21557.
8) Uruguay. Ministerio de Salud Pública. Guía de práctica clínica de detección temprana del cáncer de mama. Noviembre 2015. 40 p. Disponible en: https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/guia-practica-clinica-deteccion-cancer-mama [Consulta: 24 setiembre 2021].
9) Meissner HI, Klabunde CN, Han PK, Benard VB, Breen N. Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer 2011; 117(14):3101-11. doi: 10.1002/cncr.25873.
10) Akhigbe AO, Omuemu VO. Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city. BMC Cancer 2009; 9:203. doi: 10.1186/1471-2407-9-203.
11) Tsu VD, Jeronimo J, Anderson BO. Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ 2013; 91(9):683-90. doi: 10.2471/BLT.12.116020.
12) Abu Samah A, Ahmadian M, Latiff LA. insufficient knowledge of breast cancer risk factors among malaysian female university students. Global J Health Sci 2015; 8(1):277-85. doi: 10.5539/gjhs.v8n1p277.
13) Smith ML, Hochhalter AK, Ahn S, Wernicke MM, Ory MG. Utilization of screening mammography among middle-aged and older women. J Women Health (Larchmt) 2011; 20(11):1619-26. doi: 10.1089/jwh.2010.2168.
14) Canadian task force on preventive health care; Tonelli M, Connor Gorber S, Joffres M, Dickinson J, Singh H, Lewin G, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011; 183(17):1991-2001. doi: 10.1503/cmaj.110334.
15) Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer. CMAJ 2018; 190(49):E1441-E1451. doi: 10.1503/cmaj.180463.
16) Canadian Task Force on Preventive Health Care. Breast Cancer Update (2018). Recommendations on screening for breast cancer in women 40-74 years of age who are not at increased risk. Disponible en: https://canadiantaskforce.ca/guidelines/published-guidelines/breast-cancer-update/ [Consulta: 15 setiembre 2021].
17) Clinical Guidelines Committee of the American College of Physicians; Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ, Forciea MA, et al.Clinical Guidelines Committee of the American College of Physicians. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med 2019; 170(8):547-60. doi: 10.7326/M18-2147.
18) Breast Cancer Recommendation Statement from the U.S. Preventive Services Task Force. Ann Intern Med 2016; 164(6):448. doi: 10.7326/L16-0404.
19) Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, et al; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med 2020; 172(1):46-56. doi: 10.7326/M19-2125.
20) Uematsu T, Nakashima K, Kikuchi M, Kubota K, Suzuki A, Nakano S, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition. Breast Cancer 2020; 27(1):17-24. doi: 10.1007/s12282-019-01025-7.
2) Comisión Honoraria de Lucha Contra el Cáncer. Informe Anual. Periodo 2012-2016. Disponible en: https://www.comisioncancer.org.uy/Ocultas/RESUMENES-ESTADISTICOS-Periodo-2013-2017-uc264 [Consulta: 24 setiembre 2021].
3) Barrios E, Garau M. Cáncer: magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos. Anafamed 2017; 4(1):9-46.
4) Comisión Honoraria de Lucha Contra el Cáncer. Registro Nacional de Cáncer. Situación epidemiológica del Uruguay-Mayo 2022. Montevideo: CHLCC. Disponible en: https://www.comisioncancer.org.uy/Ocultas/Situacion-Epidemiologica-del-Uruguay-en-relacion-al-Cancer--Mayo-2019-uc108 [Consulta: 12 abril 2021].
5) Fletcher RH, Fletcher SW, Fletcher GS. Clinical epidemiology: The essentials. 5th ed. Philadelphia: Lippincott, 2013. 255 p.
6) Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151(10): 727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009.
7) Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2019; 69(3):184-210. doi: 10.3322/caac.21557.
8) Uruguay. Ministerio de Salud Pública. Guía de práctica clínica de detección temprana del cáncer de mama. Noviembre 2015. 40 p. Disponible en: https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/guia-practica-clinica-deteccion-cancer-mama [Consulta: 24 setiembre 2021].
9) Meissner HI, Klabunde CN, Han PK, Benard VB, Breen N. Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer 2011; 117(14):3101-11. doi: 10.1002/cncr.25873.
10) Akhigbe AO, Omuemu VO. Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city. BMC Cancer 2009; 9:203. doi: 10.1186/1471-2407-9-203.
11) Tsu VD, Jeronimo J, Anderson BO. Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ 2013; 91(9):683-90. doi: 10.2471/BLT.12.116020.
12) Abu Samah A, Ahmadian M, Latiff LA. insufficient knowledge of breast cancer risk factors among malaysian female university students. Global J Health Sci 2015; 8(1):277-85. doi: 10.5539/gjhs.v8n1p277.
13) Smith ML, Hochhalter AK, Ahn S, Wernicke MM, Ory MG. Utilization of screening mammography among middle-aged and older women. J Women Health (Larchmt) 2011; 20(11):1619-26. doi: 10.1089/jwh.2010.2168.
14) Canadian task force on preventive health care; Tonelli M, Connor Gorber S, Joffres M, Dickinson J, Singh H, Lewin G, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011; 183(17):1991-2001. doi: 10.1503/cmaj.110334.
15) Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer. CMAJ 2018; 190(49):E1441-E1451. doi: 10.1503/cmaj.180463.
16) Canadian Task Force on Preventive Health Care. Breast Cancer Update (2018). Recommendations on screening for breast cancer in women 40-74 years of age who are not at increased risk. Disponible en: https://canadiantaskforce.ca/guidelines/published-guidelines/breast-cancer-update/ [Consulta: 15 setiembre 2021].
17) Clinical Guidelines Committee of the American College of Physicians; Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ, Forciea MA, et al.Clinical Guidelines Committee of the American College of Physicians. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med 2019; 170(8):547-60. doi: 10.7326/M18-2147.
18) Breast Cancer Recommendation Statement from the U.S. Preventive Services Task Force. Ann Intern Med 2016; 164(6):448. doi: 10.7326/L16-0404.
19) Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, et al; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med 2020; 172(1):46-56. doi: 10.7326/M19-2125.
20) Uematsu T, Nakashima K, Kikuchi M, Kubota K, Suzuki A, Nakano S, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition. Breast Cancer 2020; 27(1):17-24. doi: 10.1007/s12282-019-01025-7.
Downloads
Published
2022-11-04
How to Cite
1.
Camejo N, Amarillo D, Castillo C, Bernate M, Burguez F, Darino E, et al. Knowledge and use of different breast cancer screening tools among primary care physicians: A cross-sectional study. Rev. Méd. Urug. [Internet]. 2022 Nov. 4 [cited 2024 Nov. 23];38(3):e38305. Available from: https://revista.rmu.org.uy/index.php/rmu/article/view/900
Issue
Section
Original Articles
